In particular, we thank Jonathan Craig, Martin Howell, David Tunnicliffe, and the ERT members for their substantial contribution to the rigorous assessment of the available evi- dence. We acknowledge Marcello Tonelli and Lyubov Lytvyn for their guidance on strengthening the linkage between the recommendations and the evidence base and for striving to improve on the format to better meet KDIGO s aspiration for a living guideline that is consistently kept up-to-date, and above all, useful and informative to practicing clinicians. We would also like to acknowledge Debbie Maizels for her vital contributions to the artwork presented in this guideline. Lastly, we acknowledge Joseph T. Flynn for his contributions to Chapter 5: Blood pressure management in children with CKD. We are especially grateful to the Work Group members for their expertise throughout the entire process of literature review, data extraction, meeting participation, and the critical writing and editing of the statements and rationale, which made the publication of this guideline possible. The generous gift of their time and dedication is greatly appreciated. Finally, and on behalf of the Work Group, we gratefully acknowledge the careful assessment of the draft guideline by public external reviewers. The Work Group considered all of the valuable comments made, and where appropriate, suggested changes were incorporated into the nal publication. 